Sotera Health Company

SHC Healthcare Diagnostics & Research

Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.

Revenue
+4.36%
EPS
+20.1%
Free cash flow
+65.0%
Total debt
+0.14%

Quarter to September 2026, against a year earlier

15.87 0.52 −3.17%
Market cap
$4.5B
P/E
26.3×
Fwd P/E
26.4×
Dividend yield
—
F-score
7/9
Altman Z
1.76
Beneish M
−2.75
Dividend safety
n/a

Sotera Health Company (SHC) Book value per share

Alert me on Book value per share

Sotera Health Company's book value per share at the end of fiscal 2025 was 2.1×, up 49.1% from 1.4× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 2.6×. Over the past ten years it has ranged from −2.8× (fiscal 2019) to 2.1× (fiscal 2025) — the current reading is the highest in ten years. Sotera Health Company ranks 28th of 49 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 2.1× 49.05%
FY2024 1.4× (9.32%)
FY2023 1.6× 26.29%
FY2022 1.3× (40.43%)
FY2021 2.1× 9.76%
FY2020 1.9× —
FY2019 −2.8× —
FY2018 0.2× —

Quarterly newest first

Period Book value per share Change
Sep 2026 2.6× 10.07%
Jun 2026 2.3× 6.60%
Mar 2026 2.2× 2.38%
Dec 2025 2.1× 10.14%
26 more quarters

Against its own ten years

Low −2.8× High 2.1×
Ten-year median 1.5×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on SHC